Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Wirtschafter E, Walts AE, Liu ST, Marchevsky AM.

Lung. 2015 Jun 24. [Epub ahead of print]

PMID:
26104490
2.

Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.

Walts AE, Hiroshima K, Marchevsky AM.

Ann Diagn Pathol. 2015 Aug;19(4):216-20. doi: 10.1016/j.anndiagpath.2015.04.006. Epub 2015 May 6.

PMID:
25979154
3.

ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.

Cheon DJ, Li AJ, Beach JA, Walts AE, Tran H, Lester J, Karlan BY, Orsulic S.

Carcinogenesis. 2015 Jul;36(7):739-47. doi: 10.1093/carcin/bgv059. Epub 2015 Apr 29.

PMID:
25926422
4.

Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.

Walts AE, Mirocha JM, Bose S.

J Cancer Res Clin Oncol. 2015 Oct;141(10):1749-56. doi: 10.1007/s00432-015-1939-9. Epub 2015 Feb 22.

PMID:
25702102
5.

TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.

Seksenyan A, Kadavallore A, Walts AE, de la Torre B, Berel D, Strom SP, Aliahmad P, Funari VA, Kaye J.

BMC Cancer. 2015 Jan 30;15:22. doi: 10.1186/s12885-015-1018-2.

6.

Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy.

Walts AE, Bomalaski JS, Ines D, Orsulic S.

J Cancer Res Clin Oncol. 2015 Aug;141(8):1363-9. doi: 10.1007/s00432-014-1904-z. Epub 2014 Dec 30.

PMID:
25548129
7.

The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?

Marchevsky AM, Wirtschafter E, Walts AE.

Hum Pathol. 2015 Feb;46(2):176-81. doi: 10.1016/j.humpath.2014.10.019. Epub 2014 Nov 12.

PMID:
25532694
8.

Computerized delineation of nuclei in liquid-based pap smears stained with immunohistochemical biomarkers.

Qin Y, Walts AE, Knudsen BS, Gertych A.

Cytometry B Clin Cytom. 2015 Mar;88(2):110-9. doi: 10.1002/cyto.b.21193. Epub 2014 Oct 3.

PMID:
25280117
9.

A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.

Cass I, Walts AE, Barbuto D, Lester J, Karlan B.

Gynecol Oncol. 2014 Sep;134(3):492-7. doi: 10.1016/j.ygyno.2014.07.084. Epub 2014 Jul 12.

PMID:
25026639
10.

BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis.

Walts AE, Pao A, Sacks W, Bose S.

Hum Pathol. 2014 May;45(5):935-41. doi: 10.1016/j.humpath.2013.12.005. Epub 2014 Jan 8.

PMID:
24746198
11.

A collagen-remodeling gene signature regulated by TGF-╬▓ signaling is associated with metastasis and poor survival in serous ovarian cancer.

Cheon DJ, Tong Y, Sim MS, Dering J, Berel D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE, Karlan BY, Orsulic S.

Clin Cancer Res. 2014 Feb 1;20(3):711-23. doi: 10.1158/1078-0432.CCR-13-1256. Epub 2013 Nov 11.

12.

Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.

Diaz ES, Walts AE, Karlan BY, Walsh CS.

Gynecol Oncol. 2013 Dec;131(3):541-5. doi: 10.1016/j.ygyno.2013.09.005. Epub 2013 Sep 14.

PMID:
24041880
13.

Follicular lesion of undetermined significance in thyroid FNA revisited.

Walts AE, Mirocha J, Bose S.

Diagn Cytopathol. 2014 Jan;42(1):18-22. doi: 10.1002/dc.23019. Epub 2013 Jul 27.

PMID:
23894017
14.

Potential errors in staging primary pulmonary adenocarcinomas by sublobar resection.

Walts AE, Marchevsky AM.

Ann Diagn Pathol. 2013 Dec;17(6):471-5. doi: 10.1016/j.anndiagpath.2013.05.006. Epub 2013 Jun 27.

PMID:
23810206
15.

Root cause analysis of problems in the frozen section diagnosis of in situ, minimally invasive, and invasive adenocarcinoma of the lung.

Walts AE, Marchevsky AM.

Arch Pathol Lab Med. 2012 Dec;136(12):1515-21. doi: 10.5858/arpa.2012-0042-OA.

PMID:
23194044
16.
17.
18.

Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.

Walts AE, Ines D, Marchevsky AM.

Mod Pathol. 2012 Sep;25(9):1258-64. doi: 10.1038/modpathol.2012.81. Epub 2012 May 11.

19.

Thyroid fine needle aspirate: a post-Bethesda update.

Bose S, Walts AE.

Adv Anat Pathol. 2012 May;19(3):160-9. doi: 10.1097/PAP.0b013e3182534610. Review.

PMID:
22498581
20.

Automated detection of dual p16/Ki67 nuclear immunoreactivity in liquid-based Pap tests for improved cervical cancer risk stratification.

Gertych A, Joseph AO, Walts AE, Bose S.

Ann Biomed Eng. 2012 May;40(5):1192-204. doi: 10.1007/s10439-011-0498-8. Epub 2012 Jan 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk